Earnings · China A-shares
Shandong Sinobioway Biomedicine Co.,Ltd. Class A (002581) earnings
Shandong Sinobioway Biomedicine Co.,Ltd. Class A published its Q3 report on 2026-10-22: net profit -98.57% year on year, -59.65% excluding one-off items. Wave Radar's earnings-quality score is 59 of 100 (Questionable). The stock moved -3.14% in the 3 trading days after the report.
- Report
- Q3 report
- Published
- 2026-10-22
- Period end
- 2026-09-30
- Net profit YoY
- -98.57%
- Excl. one-offs YoY
- -59.65%
- Result
- Bad / loss
- Quality score
- 59
- Quality
- Questionable
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | -1.67% | — |
| 3 days | -3.14% | — |
| 7 days | -14.23% | — |
| 14 days | -14.64% | — |
Report history
Over the last 8 reports, net profit grew year on year in 2 of them. The stock rose in the 3 trading days after 3 of 7 reports (average -3.88%).
| Report | Published | Net profit | Profit YoY | Excl. one-offs YoY | Revenue YoY | EPS | ROE | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 Q3 report | 2026-10-23 | -¥136.64M | -98.57% | -59.65% | +45.97% | -0.21 | -7.61% | -3.14% | — | — |
| 2026 interim report | 2026-08-28 | -¥95.47M | -41.85% | -40.06% | +32.87% | -0.14 | -5.28% | +0.97% | -6.77% | +2.92% |
| 2026 Q1 report | 2026-04-29 | -¥54.23M | -47.15% | -47.43% | +24.15% | -0.08 | -2.97% | -14.35% | -49.93% | -50.88% |
| 2025 annual report | 2026-04-29 | -¥116.28M | +15.32% | -17.49% | -23.75% | -0.18 | -6.18% | -14.35% | -49.93% | -50.88% |
| 2025 Q3 report | 2025-10-29 | -¥68.81M | -570.46% | — | -57.73% | -0.10 | -3.62% | +5.11% | +0.67% | +4.14% |
| 2025 interim report | 2025-08-20 | -¥67.30M | -127.26% | — | -66.42% | -0.10 | -3.55% | -1.69% | +3.64% | -6.41% |
| 2025 Q1 report | 2025-04-29 | -¥36.85M | -33.01% | -31.93% | -57.84% | -0.06 | -1.93% | +6.89% | +42.66% | +40.08% |
| 2024 annual report | 2025-04-24 | -¥137.31M | +58.70% | +65.02% | -16.14% | -0.21 | -6.87% | -20.95% | +6.39% | +4.12% |
The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.